Xanax isn't an evidence-based smoking cessation aid, and using a benzodiazepine for this purpose carries real dependence risk. Learn what actually works.
Jump to a section
Xanax (alprazolam) is not an evidence-based or FDA-approved smoking cessation aid, and using a benzodiazepine to manage nicotine withdrawal anxiety introduces a real dependence risk of its own — potentially trading one substance use problem for another. This article covers why this approach isn't recommended and what actually has evidence behind it.
Key Takeaways: Xanax and Smoking Cessation
- Xanax is not FDA-approved or evidence-supported specifically for smoking cessation.
- Benzodiazepines carry real dependence risk, especially with regular use over the weeks or months quitting smoking typically takes.
- Nicotine withdrawal anxiety is real but temporary, and there are safer, evidence-based ways to manage it.
- FDA-approved smoking cessation medications have much stronger evidence and a better safety profile for this specific purpose.
Why Someone Might Consider Xanax for This
Nicotine withdrawal commonly causes real anxiety and irritability, and Xanax's calming effect might seem like a logical fix. But this reasoning misses an important distinction: temporary withdrawal-related anxiety and a diagnosed anxiety disorder are different situations, and Xanax's real dependence risk makes it a poor tool for managing a temporary, time-limited symptom.
Why This Isn't a Recommended Approach
- No evidence base for smoking cessation specifically — Xanax hasn't been studied or approved for this use.
- Real dependence risk — benzodiazepines carry genuine potential for physical dependence, especially with regular use over weeks.
- Trading one dependence for another — using Xanax to manage nicotine withdrawal risks creating a new substance use problem while addressing the first.
- Withdrawal from Xanax itself requires medical supervision — adding complexity rather than solving the original problem.
What Actually Has Evidence for Smoking Cessation
- Nicotine replacement therapy — patches, gum, or lozenges, with a strong evidence base for managing withdrawal.
- Varenicline (Chantix) — specifically approved and studied for smoking cessation.
- Bupropion (Zyban) — an antidepressant also specifically approved for this purpose.
- Behavioral counseling — combined with medication, consistently improves quit rates over medication alone.
Managing Withdrawal Anxiety Without Benzodiazepines
- Understand the timeline — nicotine withdrawal anxiety typically peaks within the first week and eases over the following weeks.
- Use non-dependence-forming coping strategies — exercise, breathing techniques, and structured routine all genuinely help.
- Consider FDA-approved cessation aids — which address nicotine withdrawal directly, rather than masking anxiety with an unrelated sedative.
- Get behavioral support — counseling addresses both the anxiety and the underlying habit pattern together.
Getting the Right Support to Quit
If nicotine withdrawal anxiety feels significant, the right response is evidence-based cessation support — not an unrelated medication with its own dependence risk. Lantana Recovery's nicotine addiction treatment program and our guide to nicotine withdrawal symptoms cover what genuinely evidence-based support looks like.
FAQ: Xanax and Smoking Cessation
Is Xanax ever appropriately prescribed alongside quitting smoking?
What's the safest way to manage nicotine withdrawal anxiety?
Is nicotine withdrawal anxiety dangerous?
Bottom Line
Xanax isn't an evidence-based or approved tool for smoking cessation, and using it for this purpose risks trading nicotine dependence for benzodiazepine dependence. FDA-approved options combined with behavioral support offer a safer, more effective path to quitting. Our guide on Xanax's own dependence risk covers this medication in more depth.
Sources
- FDA — Approved Smoking Cessation Medicationshttps://www.fda.gov/tobacco-products/products-ingredients-components/smoking-cessation
- DEA — Benzodiazepines Drug Fact Sheethttps://www.dea.gov/factsheets/benzodiazepines
Reviewed by
Warren PhillipsCo-Founder, LMSW · Editorial Reviewer
Warren Phillips is a Co-Founder of Lantana Recovery and a Licensed Master Social Worker (LMSW) specializing in substance abuse and mental health treatment. He previously worked in various capacities at Turnbridge Addiction Treatment and Clearpoint Recovery Center before co-founding Lantana Recovery. Warren's clinical approach draws on a strengths-based perspective, Twelve Step philosophies, Cognitive Behavioral Therapy, and Motivational Interviewing. He brings both personal and professional experience to his work — as a person in long-term recovery from alcohol and illicit substances, he has used that experience to help shape Lantana's treatment programming. Warren grew up in Memphis, TN and St. Louis, MO, attended college in Mississippi, and lived in California and Connecticut before relocating to Charleston. He now lives in Mount Pleasant with his wife, Angela, and their two young children, Hall and Sam.
Written by the Lantana Recovery Editorial Team and reviewed for clinical accuracy before publication.
